Co-founder & VP – Vector Design, Infinitopes Cancer Vaccines | Honorary Researcher, Univ. of Oxford. Interests: multi-antigen vaccine designs & cancer vaccines
Joined April 2012
- Tweets 100
- Following 800
- Followers 220
- Likes 615
Photos and videos
10 Dec 2021
Exciting data from Phase 1b/2a on Therapeutic HBV vaccine and Nivolumab combo. Early evidence that a therapeutic vaccine can cure chronic HepB infection is emerging…
8 Dec 2021
Our viral vectored HBV T cell vaccine given as prime boost with anti-PD1 shows SAg decline/loss in chronic HBV. Small numbers-but very excited to see early data showing promise for a new vaccine for a global disease that drives liver cirrhosis/cancer. investors.vaccitech.co.uk/ne…
3
Senthil Chinnakannan retweeted
17 Nov 2021
We are recruiting TWO fantastic post doctoral scientists at Barnes Lab and @PKlenermanLab following a U19 award to develop novel HCV vaccines: 1) in advanced cellular immunology (attached) and 2) molecular vaccinology (vaccine design & generation) [to follow]. Great opportunity!
19
41
54
Senthil Chinnakannan retweeted
23 Apr 2021
👩🔬 3,000 researchers
🙋 24,675 volunteers
🌎 Delivered to 170 countries
💉 300,000,000 doses worldwide
Today marks the one-year anniversary of the first dose of the #OxfordVaccine being given.
Here are some of the things we've done in that year:
13
116
368
Senthil Chinnakannan retweeted
7 Dec 2019
In continuation of enhanced defence cooperation between 🇮🇳 and 🇧🇩, Indian Army gifts 10 Mine Detection Dogs (MDDs) to Bangladesh Army as a goodwill gesture at Petrapole-Benapole ICP in a ceremonial function.
@easterncomd
@adgpi
1
6
25
Senthil Chinnakannan retweeted
11 Feb 2021
Our Our paper in pre-print: researchsquare.com/article/r…
Robust T cells after 2 doses of pfizer vaccine against variants of concern. But no neutralising Abs against B1.351 after one dose theguardian.com/world/2021/f…
4
26
69
Senthil Chinnakannan retweeted
23 Nov 2020
90% efficacy at lower dose (= more available vaccine to vaccinate more people) plus 2-8 oC cold storage that can integrate into existing supply chains >> greater potential distribution.
All in 8 months?! Amazing work. And the result of decades of fundamental academic research!
23 Nov 2020
Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one step closer to supplying it at low cost around the world>> bit.ly/oxford-vaccine-result…
3
3
12
6 Nov 2020
If you are a PhD student with entrepreneurship interest/potential, do signup for the programme. ConceptionX has an excellent package of entrepreneurial training and coaching sessions.
6 Nov 2020
If you're considering applying for our 2021 cohort, we have another discovery session coming up!
Sign up here and ask us questions about the programme 👉 eventbrite.co.uk/e/conceptio…
#venturescience #deeptech #innovation
1
4
Senthil Chinnakannan retweeted
24 Oct 2020
I have a position in my group for a post-doc investigating host-virus genomics, based at Oxford University. Please pass it on to anyone who might be interested.
my.corehr.com/pls/uoxrecruit…
1
39
30
Senthil Chinnakannan retweeted
24 Jul 2020
Hi Twitter! We're looking for an RA in my @vGlycoproteins lab. Starts ASAP, until Sept 2021, on a really cool Nipah vaccines project with @PRRS_Immunol. If you're interested in nAb responses, vaccine dev' and emerging diseases this IS the job! isw.changeworknow.co.uk/pirb…
Please RT
1
40
25
Senthil Chinnakannan retweeted
21 Jul 2020
1) There is a lot of talk about decaying antibodies. I would like to walk you through a few findings about antibodies to SARS-CoV-2 that we put on medRxiv on Friday. Ill do this slowly over the day (while being in nonstop conference calls). But I feel this needs to get out there.
194
3,567
8,689
Senthil Chinnakannan retweeted
2 Jul 2020
The #Ebola vaccine, tested and verified by the University of Oxford, has now been approved by the European Commission. Find out more about this incredible milestone in the fight against Ebola outbreaks: bit.ly/3inXmBx
16
197
474
Senthil Chinnakannan retweeted
18 Jun 2020
Thanks leo! Class II invariant chain as a gentic adjuvant. Its a transferable technolgy to everyone who wants to enhance T cell immunity. Vaccines for cancer and infectious disease. 4 years of work . Thanks to the whole team.
18 Jun 2020
One of the most interesting things I have worked on and one of the bits of science I enjoyed the most is out now in @ScienceTM. Worth a read for anyone interested in T cells, vaccines, HCV or antigen presentation! 🤓🧬@EleanorBarnesOx @IlariaE09929587 stm.sciencemag.org/content/1…
3
6
21
Senthil Chinnakannan retweeted
14 May 2020
Preclinical data showing promising immune responses and prevention of #Covid_19 pneumonia with @jennerinstitute
#vaccine
"ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques" biorxiv.org/content/10.1101/…
1
13
38
Senthil Chinnakannan retweeted
11 May 2020
Happy 2nd Birthday, @conceptionxtech! What a journey. From a small pilot @UCLEngineering, we are now riding the wave of #deeptech innovation; propelling #PhDs from across the UK on their mission #venture scientists. All thanks to this wonderful team, our partners, and friends!
1
2
18
Senthil Chinnakannan retweeted
2 May 2020
Suddenly...
...DUCKS
42
165
990
Senthil Chinnakannan retweeted
2 May 2020
Thanks mike..a super useful summay of the T cell literature. Can I request one weekly!
15 Apr 2020
CD8 T cells play an important role in clearing respiratory virus. I looked at 10 preprints from @biorxivpreprint and @medrxivpreprint all exploring T cell responses to #SARS2/#COVID19. In no particular order, here’s what I found interesting, and then some comments below. 1/17
2
10
Senthil Chinnakannan retweeted
2 May 2020
ChAdOx1 vaccinations shown to be protective against MERS (another coronavirus) in NHPs and mice, with just one vaccination. This is timely and good news!!!
1
5
13
Senthil Chinnakannan retweeted
30 Apr 2020
The University has entered into a partnership with @AstraZeneca on the development and manufacture of the COVID-19 vaccine currently undergoing clinical trials at Oxford ox.ac.uk/news/2020-04-30-lan…
1
9
19